Cardioprotection by farnesol: role of the mevalonate pathway.
Szűcs G, Murlasits Z, Török S, Kocsis GF, Pálóczi J, Görbe A, Csont T, Csonka C, Ferdinandy P.
Szűcs G, et al. Among authors: gorbe a.
Cardiovasc Drugs Ther. 2013 Aug;27(4):269-77. doi: 10.1007/s10557-013-6460-2.
Cardiovasc Drugs Ther. 2013.
PMID: 23673412